Rats (Sprague-Dawley) and mice (Balb/c) were given microcystin LR intraperitoneally and were killed at intervals up to 24 hr (rats) or 90 min (mice) and necropsied. The lowest consistently lethal dose was 160 pg/kg in rats and 100 pg/kg in mice. Rats that were clinically unaffected had no lesion. All clinically affected rats in all dose groups died (from 20 to 32 hr after toxin) and had similar hepatic lesions. Livers were enlarged and dark red beginning 40 to 60 min after toxin. Mild disassociation and rounding of centrilobular hepatocytes developed within 20 min. By 60 rnin after toxin, degeneration and necrosis of hepatocytes involved most of the lobules except for small periportal zones. Weights of livers and kidneys were significantly increased. Eosinophilic fibrillar material filled renal glomerular capillaries as early as 9 hr after toxin. At 18 to 24 hr there was moderate vacuolation of proximal tubular epithelium with mild tubular dilatation. Beginning at 1 hr, intact hepatocytes and hepatic debris were present in pulmonary vessels. Analysis of serum revealed an increase in alanine aminotransferase 40 min after toxin; at 6 to 12 hr there were significant increases in alkaline phosphatase, total bilirubin, blood urea nitrogen, and creatinine. Mice survived only 60 to 90 rnin after toxin. Hepatic lesions were similar to those in rats, but renal and pulmonary lesions were not seen.
Toxins produced by the blue-green algae, Microcystis aeruginosa, have produced hepatotoxicity in sheep and cattle and have been implicated in human illnesses associated with proliferation of algae in reservoirs. Hepatotoxicity has been experimentally reproduced in pigs (Hooser, unpublished data), sheep, mice, rats, guinea pigs, rabbits, chickens, ducks, and calves by dosing with whole cells or toxin extract^.^,^.^.^-' l , l 6 -I 8 The pathogenesis and mechanism of action are not known. It has been hypothesized that hepatic damage may be due to a direct hepatotoxic effect,'~~ to venous hypertension caused by massive pulmonary thrombosis,l,17 or to stimulation of the sympathetic nervous system leading to vasoconstriction with subsequent hepatic pooling of blood and peripheral anoxia. 13 Death may be due to hypovolemic shock associated with hepatic necrosis and hemorrhage or to pulmonary embolism with subsequent venous hypertension, reduced cardiac output, and circulatory ~o l l a p s e .~J~ Sequential serum chemistry and corresponding morphologic alterations using purified toxin have not yet been reported in rats.
In the present study we characterize the acute toxicity of the purified heptapeptide hepatotoxin, microcystin LR (cyanoginosin LR) produced by the laboratory strain 7820 of Microcystis aeruginosa. We have examined clinical signs and pathologic changes, and have compared our findings to results obtained by others using cells or toxin extracts. Using the purified hepatotoxin we evaluated and compared the toxic effects: (a) in male and female rats; (b) in male rats at minimal lethal doses and at doses greatly in excess of the minimum lethal dose; and (c) in mice and rats. In addition, we characterized the sequential morphologic and clinical pathologic changes occurring in male rats at a minimally lethal dose of the hepatotoxin.
Materials and Methods

Animals
Male and female 175-200 g Sprague-Dawley rats were obtained from Harlan Sprague-Dawley, Inc. (Indianapolis, IN) and allowed to acclimate for 2 weeks or longer before use. Adult female Balb/c mice, raised in our own colony, were also used. Animals had free access to a commercial laboratory chow and water and were maintained on a 12-hr light: dark cycle.
Rats and mice were randomly assigned to the various dose groups immediately before dosing and then given free access to food and water until termination of the study.
Toxin
Microcystin LR (MCLR-approximately 9 5% pure) from Microcystis aeruginosa, laboratory strain 7820, was produced and purified in our (W. W. Carmichael) laboratory by meth-anol/butanol cell extraction, centrifugation, sephadex filtration, and purification by high performance liquid chromatography.12 MCLR was dissolved in 0.9% NaCl prior to use.
Pathologic examination
Animals not dying spontaneously were anesthetized with ether and killed by exsanguination. They were then weighed and necropsied. In the sequential studies, livers, kidneys (with adrenals), and spleens were weighed. Lungs were fixed by intratracheal instillation of 10% neutral buffered formalin. Sections of liver, lungs, kidneys, spleen, and thymus from all animals, as well as brain, heart, adrenal glands, small and large intestine, pancreas, urinary bladder, skeletal muscle, and eyes of rats from the acute toxicity study, were fixed by immersion in 10% neutral buffered formalin. Tissues were then routinely processed, embedded in paraffin, cut at 4-6 pm, stained with hematoxylin and eosin (HE), and examined by light microscopy. Selected kidney sections in the sequential morphologic study were stained for fibrin deposition with phosphotungstic acid hematoxylin, Martius scarlet blue trichrome, Martius yellow scarlet red analine blue, or Carstair's stains, or for calcium deposition with Von Kossa's stain or Alizarin red stain.
Acute toxicity in rats
Male rats (two to eight per group [ Table 11 ) were given an intraperitoneal (ip) injection of MCLR at the following doses: 20, 40, 80, 120, 160, 180, 200, 240, or 400 pg/kg. Volumes administered ranged from 0.1 to 1 .O ml. Animals were then observed continuously for clinical signs of toxicasis for 12 hr and periodically thereafter. Similarly, female rats (three per group) were given an ip injection of MCLR at 40, 80, 120, or 160 pg/kg. Surviving animals were killed 5 days after treatment.
In addition, male rats (three per group) were given a single ip injection of MCLR at the following doses: 0 (2 ml of the vehicle, 0.9% NaCl), 400, 800, or 1,200 pg/kg. Surviving animals were killed 24 hr after treatment.
Sequential acute toxicity study in rats
Male rats (two to seven per group) were given an ip injection of a lethal dose of MCLR (160 pg/kg) and killed with ether at the following times: 5, 10, 20, 30, 40, 50, or 60 min, and 3, 6, 9, 12, 18, or 24 hr. No animals died spontaneously. Control rats (three per group) were injected ip with 0.5 ml of 0.9% NaCl and killed at 60 min and at 12 and 24 hr. Immediately prior to necropsy, blood samples were collected by cardiac puncture, immediately placed in serum tubes or tubes containing ethylenediaminetetraacetic acid (EDTA) as an anticoagulant, and put on ice. Clotted serum samples were centrifuged within 1 hr of collection, the clots were removed, and the samples were frozen until analyzed. Serum chemistry parameters evaluated included: creatinine, blood urea nitrogen, total protein, albumin, calcium, phosphorus, sodium, potassium, chloride, glucose, alkaline phosphatase, alanine aminotransferase (ALT = serum glutamic-pyruvic transaminase), gamma glutamyl transferase, total bilirubin, albumin to globulin ratio, and sodium to potassium ratio. 
Sequential morphologic alterations in mice
Female mice were given an ip injection of 100 pg/kg of MCLR and killed (two per group) at 15, 30, 60, and 90 min post-dosing. Three mice that died at 90 to 120 min postdosing were necropsied immediately. Control mice (given 0.9% NaC1) were killed at 120 min post-dosing.
Statistical analysis
Serum chemistry data were analyzed using a one-way analysis of variance (SAS Institute, SAS Circle, Cary, NC) with Tukey's comparison of means to evaluate differences between individual times. Since controls were not done at each individual time point, all control data were pooled to compare to the observations from treated rats. Results were considered significant when P < 0.05.
Results
Acute toxicity in rats
Male rats dosed at 20, 40, or 80 pg/kg and female rats dosed at 40 pg/kg did not have any clinical signs of toxicity and had no gross or microscopic lesions. Variable numbers of animals dosed between 40 pg microcystin LR (MCLR)/kg (females) or 80 pg MCLR/ kg (males) and 160 pg MCLR/kg were affected ( Table  1 ). All clinically unaffected animals had no lesions. All clinically affected animals in all dose groups died and had similar gross and histologic lesions irrespective of sex or dose. Clinical signs in affected animals consisted, of lethargy and ruffling of fur which began several hr after toxin administration and increased in severity until the time of death. Time from injection of the hepatotoxin to death ranged from 20 to 32 hr in both males and females injected with less than 240 pg/kg of the toxin. All rats given very high doses of MCLR (400-1,200 pg/kg) died 6 to 8 hr following treatment (Table 1) .
Gross lesions were seen only in the liver. Livers from all rats which died were dark red and enlarged, espe- cially from those receiving the higher doses. Severe centrilobular and midzonal necrosis, with occasional degenerate and necrotic hepatocytes in central veins, were seen with equal severity in all affected rats of both sexes. Glomerular capillaries frequently contained eosinophilic, finely fibrillar to homogeneous material. Renal cortical proximal tubular epithelial cells were moderately vacuolated, and scattered tubules were mildly dilated and contained moderate amounts of homogeneous, basophilic to eosinophilic material. With very high doses there were multifocal areas of tubular epithelial necrosis with small amounts of luminal necrotic debris. Many pulmonary capillaries and larger vessels were dilated and contained eosinophilic globular debris or intact cells which appeared to be hepatocytes. Other tissues were unaffected.
Sequential acute toxicity study in rats
Clinical signs were similar to those seen in the acute studies. Livers from hepatotoxin-treated (1 60 Mglkg) rats killed as early as 40 to 60 min after treatment were dark red and enlarged. Liver weight (as % of body weight) of treated rats was significantly (P = 0.01) greater than that of controls over the 24-hr time period (Fig.  1 ). No other gross lesions were noted. Kidney weight (as O/o of body weight) progressively increased beginning at 3 hr post-dosing (Fig. 2) . Spleen weight of toxintreated animals did not differ from that of controls.
Hepatic lesions were first seen at 20 min and consisted of mild disassociation and rounding of centrilobular hepatocytes. At 60 min there was severe hepatocyte disassociation, degeneration, and necrosis with severe hepatocyte loss and hemorrhage ( Fig. 3) throughout the entire liver lobule, except for areas approximately six to seven cells wide surrounding portal regions. Central veins were frequently replaced by disassociated hepatocytes, cellular debris, and erythrocytes ( Fig. 4) . Intact central veins frequently contained hepatocytes or hepatic debris (Fig. 5 ). The lesions increased in severity until at 9 to 24 hr post-dosing there was a progressive reduction in the number of cells with the remaining cellular debris intermingled with red blood cells ( Fig. 6 ).
Beginning 60 min after dosing, scattered renal cortical tubules contained progressively increasing amounts of homogeneous, basophilic material. Beginning at 9 hr post-dosing, glomerular capillaries contained small amounts of eosinophilic, fibrillar material which did not stain for fibrin with phosphotungstic acid hematoxylin, Martius scarlet blue trichrome, Martius yellow scarlet red analine blue, or Carstair's stains. Scattered basophilic stippling that did not stain for calcium with Von Kossa's or Alizarin red stains was present within the eosinophilic material. By 18 hr post-dosing, cortical proximal tubular epithelial cells frequently contained one to several variably sized, clear, intracytoplasmic vacuoles.
Beginning 1 hr post-dosing, many pulmonary capillaries and arterioles contained eosinophilic granular debris or intact rounded cells (Figs. 7, 8 ). These cells had abundant eosinophilic cytoplasm, occasional binucleate and frequently pyknotic nuclei, and were much larger than erythrocytes or leukocytes. In all rats killed between 12 and 24 hr post-dosing, the cells in the pulmonary capillaries became increasingly degenerate with nuclear karyolysis and intracytoplasmic vacuolation. This correlated with the increased hepatocyte de- Fig. 3 . Centrilobular hepatocyte degeneration, disassociation, and rounding with small areas of hemorrhage, 1 hr postdosing; liver from rat injected intraperitoneally with 160 pg microcystin LWkg. HE. Fig. 4 . Increased loss of centrilobular architecture with destruction of central vein (arrowhead) and increased hepatocyte degeneration and necrosis, 3 hr post-dosing; liver from rat injected intraperitoneally with 160 pg microcystin LWkg. HE. Fig. 5 . Hepatocytes in central vein (arrowheads), 1 hr post-dosing; liver from rat injected intraperitoneally with 160 pg microcystin LWkg. HE. Fig. 6 . Most hepatocytes, except for a rim periportally, have been replaced by necrotic debris and erythrocytes, 24 hr post-dosing. Portal vein (P); liver from rat injected intraperitoneally with 160 pg microcystin LWkg. HE. generation and necrosis in the liver observed at the same time points. The morphology as well as the nuclear pyknosis and cytoplasmic vacuolation of these cells was identical to that of affected hepatocytes.
Statistically significant increases were seen in the serum activities of the enzymes alanine aminotransferase (ALT) (P = 0.003) and alkaline phosphatase (ALP) (P = 0.001), and in blood urea nitrogen (BUN) (P = 0.001) and creatinine (P = 0.002) from treated animals as compared to controls. Beginning at 40 min, there was an increase in ALT which continued until the end of the study (Figs. 9, 10 ). ALP (Fig. 11 ) and total bilirubin (Fig. 12) several central veins. In the kidney, mild dilation of cortical tubules was first seen 60 min post-dosing and became more severe by 90 min. Many tubules contained eosinophilic granular to fibrillar material. Similar material was occasionally noted in Bowman's space and in glomerular capillaries. No treatment-related lesions were seen in the lungs.
Discussion
The liver is the major target organ of the microcys-
The marked hepatocyte disassociation and necrosis which occurred in rats and mice in our experiments are similar to that reported in mice and sheep given whole cells or toxin extracts. An exception de~cribed.~ No differences were noted in the response of male rats as compared to females. A steep doseresponse curve was found with no effect below 80 pg/ kg and virtually 100% lethality above 160 pg/kg. After a single intraperitoneal (ip) exposure, rats injected with Fig. 7 . Pulmonary capillaries containing intact hepatocytes and erythrocytes. One hepatocyte is binucleate (arrowneally with 160 pg microcystin LWkg. HE. Fig. 8 . Pulmonary vessel containing several hepatocytes and erythrocytes. One hepatocyte is binucleate (arrowhead), 6 hr post-dosing; lung from rat injected intraperitoneally with 160 pg microcystin LR/kg. HE. head), 3 hr post-dosing; lung from rat injected intraperito-is One study in mice in which periportal necrosis was 80-160 p g microcystin LR (MCLR)/kg were either clinically affected and died with massive liver destruction and hemorrhage, or were clinically unaffected and had no gross or microscopic lesions. In both rats and mice, microscopic lesions were present in the liver as early as 20 to 30 min post-dosing. At 60 rnin the histologic lesions in rats were comparable to those in mice. However, while mice died at 60 to 90 rnin postdosing, rats survived for 20 to 32 hr. Even with doses greater than 240 pdkg of MCLR, the survival time in rats was still 6 to 8 hr. The reason for this species difference is intriguing but undetermined at the present time.
A good correlation was found between the initial hepatocyte lesions seen at 30 rnin and the initial increase in alanine aminotransferase (ALT) at 40 rnin post-dosing. The increases in alkaline phosphatase (ALP) and total bilirubin, while more often correlated with biliary obstruction, can also be related to necrosis with release of these enzymes into the circulation. This contrasts with the effects of M. aeruginosa toxin extracts when added to suspensions of isolated hepatocytes. Although isolated hepatocytes had morphologic changes (plasma membrane blebbing) within 5 to 10 min, intracellular enzymes are not released for 60 to 100 min.3J"16 Possible explanations are that hepatocytes are altered during isolation, some contributing factor is present in vivo which is not present in vitro, or that the number of hepatocytes damaged in vivo is large enough to allow an increase in ALT to be detected earlier than in vitro. The decrease in serum glucose may be due to the inability of the damaged liver to convert glycogen to glucose or to synthesize glucose from precursor molecules. Endothelial damage in the liver was evident from the observation of massive hemorrhage and loss of central veins and sinusoidal architecture. Whether the initial effect was on the endothelial cells or on hepatocytes, with subsequent endothelial damage, is unclear at this time. However, breakdown in hepatic endothelial integrity, in conjunction with massive hepatocyte disassociation, appears to allow intact hepatocytes and necrotic cellular debris into the venous circulation, subsequently into the pulmonary artery, and eventually into the lungs. Much later in the course of the toxicosis this debris is thought to be deposited as eosinophilic fibrillar material in the renal glomerular capillaries. In rats, necrotic debris and intact cells were seen in the pulmonary vasculature as early as 1 hr postdosing. Recent ultrastructural studies have confirmed that these cells are hepatocytes (unpublished data). It must be stressed that severe hepatic lesions preceded the finding of intact cells and necrotic cellular debris in the pulmonary vasculature. Thus, the hypothesis that pulmonary thrombosis causes an increase in venous pressure and is responsible for hepatic damage should be discounted. In our studies, hepatocyte microemboli, although present in many pulmonary vessels, did not appear to cause significant pulmonary or extrapulmonary damage. We did not see such intact cells in the pulmonary circulation of mice. The release of intact cells and cell fragments from the liver into the venous circulation has not been seen with other hepatotoxins and thus appears to be unique to MCLR. Pulmonary thrombosis and embolism have been described previously and reported as being acellular. 1, 17 Renal tubular lesions in mice and rats were suggestive of glomerular damage with leakage of protein into cortical tubules. Renal lesions were more extensive in rats than mice, again perhaps due to the short time to death in mice. In rats, the presence of large amounts of eosinophilic material within glomerular capillaries at 18 and 24 hr coincided with increased amounts of eosinophilic to basophilic material within the lumens of renal cortical tubules. This could also be from ischemia due to hypovolemic shock with damage to glomerular capillaries. Renal proximal tubular necrosis was evident in rats at very high doses of MCLR. This may be due to a direct effect of the toxin on the tubular epithelium or, more likely, to a secondary ischemic effect from shock induced by the massive hepatic necrosis and hemorrhage. It is possible that this is exacerbated by partial obstruction of glomerular and peritubular capillaries with the eosinophilic fibrillar material observed. Recent ultrastructural studies (unpublished) indicate that this material is hepatic debris. The time at which renal lesions were seen roughly correlated with the elevation of blood urea nitrogen and creatinine.
While the exact mechanism of action of the toxin produced by Microcystis aeruginosa remains to be determined, death in affected animals is due to massive hepatic destruction and hemorrhage resulting in severe circulatory shock and loss of liver function.
